GENOMINE corporation is a biotech company dedicated to develop technologies and products of in-vitro diagnostics field. Based on our proprietary proteome related technology and the other technologies on diagnostic target validation and product development, we detect and identify novel diagnostic biomarkers and companion diagnostic biomarkers. Diagnostic products are developed in the platform of bead-based immunoassay, multiple-panel immunoassay and solid-based immunoassay platform.

We develop products in one stop platform from up-stream biomarker identification to down-stream immunoassay. And we are until now still evolving in the reach and development with the aim for the equipment of cutting-edge technology and for the production of in-vitro diagnostics capable of overcoming current limitation.